Locally advanced mucinous carcinoma of the breast with sudden growth acceleration: A case report

Japanese Journal of Clinical Oncology

Volumn 32, Issue 2, 2002, Pages 64-67

  Ishikawa, Takashi ^a   Hamaguchi, Yohei ^a   Ichikawa, Yasushi ^a   Shimura, Miei ^a   Kawano, Naomi ^a   Nakatani, Yukio ^a   Ohnishi, Hideki ^a   Maegawa, Jiro ^a   Ogino, Ichiro ^a   Shimada, Hiroshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Breast; Combined treatment; Mucinous carcinoma

Indexed keywords

ESTROGEN; PACLITAXEL; PIRARUBICIN; PROGESTERONE; ANTINEOPLASTIC AGENT; DOXORUBICIN; DRUG DERIVATIVE;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER GRADING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; HYPERTHERMIC THERAPY; LATISSIMUS DORSI MUSCLE; LYMPH NODE METASTASIS; MASTECTOMY; MUCINOUS CARCINOMA; MYOCUTANEOUS FLAP; RECTUS ABDOMINIS MUSCLE; RECURRENT DISEASE; TUMOR GROWTH; TUMOR VOLUME; BREAST TUMOR; COLLOID CARCINOMA; DISEASE COURSE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION DOSE;

ADENOCARCINOMA, MUCINOUS; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOXORUBICIN; FEMALE; HUMANS; MASTECTOMY, RADICAL; PACLITAXEL; RADIOTHERAPY DOSAGE;

EID: 0036480451     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyf012     Document Type: Article

References (13)

1. Diab SG, Clark GM, Osborne CK, Libby A, Allred DC, Elledge RM. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol 1999;17:1442-8.
2. Avisar E, Khan MA, Axelrod D, Oza K. Pure mucinous carcinoma of the breast: clinicopathologic correlation study. Ann Surg Oncol 1998;5:447-51.
3. Rosen PP, Lesser ML, Kinne DW. Breast carcinoma at the extremes of age: a comparison of patients younger than 35 years and older than 75 years. J Surg Oncol 1985;28:90-6.
4. Toikkanen S, Kujari H. Pure and mixed mucinous carcinomas of the breast: a clinicopathologic analysis of 61 cases with long-term follow-up. Hum Pathol 1989;20:758-64.
5. Fentiman IS, Millis RR, Smith P, Ellul JP, Lampejo O. Mucoid breast carcinomas: histology and prognosis. Br J Cancer 1997;75:1061-5.
6. Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A. Tumour development, histology and grade of breast cancers: prognosis and progression. Int J Cancer 1996;66:413-9.
7. Andre S, Cunha F, Bernardo M, Menesese Sousa J, Cortez F, Soares J. Mucinous carcinoma of the breast: a pathologic study of 82 cases. J Surg Oncol 1995;58:162-7.
8. Komaki K, Sakamoto G, Sugano H, Morimoto T, Monden Y. Mucinous carcinoma of the breast in Japan. A prognostic analysis based on morphologic features. Cancer 1988;61:989-96.
9. Paridaens R, Biganzoli L, Bruning P, Klijn JG, Gamucci T, Houston S, et al. Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over. J Clin Oncol 1999;17:3828-34.
10. Moliterni A, Tarenzi E, Capri G, Terenziani M, Bertuzzi A, Grasselli G, et al. Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer. J Clin Oncol 2000;18:724-33.
11. Sparano JA, Hu P, Rao RM, Falkson CI, Wolff AC, Wood WC. Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group study. Semin Oncol 1997;24(1 Suppl 3):S1-S3.
12. McCarter DH, Doughty JC, Cooke TG, McArdle CS, Reid AW. Selective angiographically delivered regional chemotherapy in patients with locally advanced or recurrent breast cancer: a feasibility study. J Vasc Interv Radiol 1998;9(1 Pt 1):91-6.
13. Murakami M, Kuroda Y, Nishimura S, Sano A, Okamoto Y, Taniguchi T, et al. Intraarterial infusion chemotherapy and radiotherapy with or without surgery for patients with locally advanced or recurrent breast cancer. Am J Clin Oncol 2001;24:185-91.